01 1Zhejiang Huahai Pharmaceutical
01 1BREXPIPRAZOLE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-04
Pay. Date : 2019-04-26
DMF Number : 33810
Submission : 2019-04-25
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BREXPIPRAZOLE, with a corresponding US DMF Number 33810.
Remarkably, this DMF maintains an Active status since its submission on April 25, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 04, 2019, and payment made on April 26, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
